Sanofi (SNY) 'Seemingly Committed' to MannKind's (MNKD) Afrezza, RBC Says; 2nd-Half Efforts to Focus on Awareness
RBC Capital analyst Adnan Butt weighed in on MannKind (NASDAQ: MNKD) after partner Sanofi's (NYSE: SNY) update at ADA included ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
